General Information of Drug (ID: DM4FOX0)

Drug Name
AK107 Drug Info
Synonyms
2,5-Bis[4-(1H-imidazol-2-yl)phenyl]-1,3-oxazole; 2,5-bis[4-(1H-imidazol-2-yl)phenyl]-1,3-oxazole; AK.107; AC1LARBL; CTK5J5532; 2,5-bis[4-(1H-imidazol-2-yl)phenyl]oxazole; 2,5-Bis(4-imidazol-2-ylphenyl)-1,3-oxazole
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
PubChem CID
473613
TTD Drug ID
DM4FOX0

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Immune checkpoint (ICH)
Drug Name Drug ID Indication ICD 11 Highest Status REF
NLG919 DMYPWHD Solid tumour/cancer 2A00-2F9Z Phase 1 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Immune checkpoint (ICH) TTV8N19 NOUNIPROTAC Inhibitor [1]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Deal watch: Genentech dives deeper into the next wave of cancer immunotherapies. Nat Rev Drug Discov. 2014 Dec;13(12):879.